Varian Medical Systems
14
30M
10
0.18
4
0.29
2
- Areas of investment
Summary
Varian Medical Systems is the famous Corporate Investor, which was founded in 1948. The company was established in North America in United States. The main office of represented Corporate Investor is situated in the Palo Alto.
Considering the real fund results, this Corporate Investor is 47 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2018. Opposing the other organizations, this Varian Medical Systems works on 12 percentage points less the average amount of lead investments. The top activity for fund was in 2019.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Varian Medical Systems, startups are often financed by iSeed Ventures, BioAdvance, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are TPG Biotech, Seroba Life Sciences, Johnson & Johnson Innovation. In the next rounds fund is usually obtained by Catalyst Health Ventures, TPG Biotech, Sparta.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular fund investment industries, there are Biotechnology, Biopharma. The fund has no exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight Fusion Pharmaceuticals, HistoSonics, Oncora Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Investments analytics
Analytics
- Total investments
- 14
- Lead investments
- 4
- Exits
- 2
- Rounds per year
- 0.18
- Follow on index
- 0.29
- Investments by industry
- Health Care (10)
- Medical (9)
- Medical Device (8)
- Biotechnology (4)
- Health Diagnostics (3) Show 16 more
- Investments by region
-
- United States (10)
- Canada (3)
- Israel (1)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Avg. valuation at time of investment
- 60M
- Group Appearance index
- 0.64
- Avg. company exit year
- 11
- Avg. multiplicator
- 13.99
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Arterys | 29 May 2020 | Health Care, Health Diagnostics, Medical Device, Medical, Cloud Computing | Late Stage Venture | 28M | United States, California, San Francisco |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.